HISTOPATHOLOGICAL HETEROGENEITY IN FULMINANT HEPATIC-FAILURE

被引:20
|
作者
HANAU, C
MUNOZ, SJ
RUBIN, R
机构
[1] THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,DEPT MED,PHILADELPHIA,PA 19107
[2] THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,DEPT PATHOL,PHILADELPHIA,PA 19107
关键词
D O I
10.1002/hep.1840210213
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The clinicopathological features of 38 patients admitted consecutively for fulminant hepatic failure were studied, Histopathological material was reviewed in all patients. Both percutaneous and whole Livers (either explanted or autopsy specimens) were available in 16 patients: whole livers only in 12 patients and biopsy specimens only in 10 patients. All patients were negative for antibodies to hepatitis C, whereas 24% had hepatitis B infection and 10% had adverse drug reactions. Livers from 75% of patients showed confluent hepatic necrosis. However, there was considerable variability in the extent of necrosis, and biopsy specimens from about 50% of the most severely affected livers showed only minimal bridging necrosis, In patients with massive hepatic necrosis, percutaneous liver biopsy specimens were frequently misleading because of regional inhomogeneities. Interestingly, five patients (13%) had established cirrhosis at the time of diagnosis. The best clinical predictors of survival were age and the maximal grade of encephalopathy. By contrast, neither the severity of confluent hepatic necrosis nor the etiology predicted the decision to transplant or the outcome, There were no differences in the histopathology corresponding to different etiologies, In summary, the approach to the patient with fulminant hepatic failure should be guided principally on clinical grounds, and further classification should be based on pathological and etiologic considerations. However, histological classification and prognosis based on percutaneous biopsy specimens alone may be misleading.
引用
收藏
页码:345 / 351
页数:7
相关论文
共 50 条
  • [1] FULMINANT HEPATIC-FAILURE
    TYGSTRUP, N
    RANEK, L
    [J]. CLINICS IN GASTROENTEROLOGY, 1981, 10 (01): : 191 - 208
  • [2] FULMINANT HEPATIC-FAILURE
    LIDOFSKY, SD
    [J]. CRITICAL CARE CLINICS, 1995, 11 (02) : 415 - 430
  • [3] FULMINANT HEPATIC-FAILURE
    KATELARIS, PH
    JONES, DB
    [J]. MEDICAL CLINICS OF NORTH AMERICA, 1989, 73 (04) : 955 - 970
  • [4] FULMINANT HEPATIC-FAILURE
    FINGEROTE, RJ
    BAIN, VG
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 1993, 88 (07): : 1000 - 1010
  • [5] FULMINANT HEPATIC-FAILURE
    MARTIN, P
    PAPPAS, SC
    [J]. DIGESTIVE DISEASES, 1990, 8 (03) : 138 - 151
  • [6] FULMINANT HEPATIC-FAILURE
    RIEGLER, JL
    LAKE, JR
    [J]. MEDICAL CLINICS OF NORTH AMERICA, 1993, 77 (05) : 1057 - 1083
  • [7] FULMINANT HEPATIC-FAILURE
    HETZEL, DJ
    [J]. ANAESTHESIA AND INTENSIVE CARE, 1985, 13 (03) : 272 - 282
  • [8] FULMINANT HEPATIC-FAILURE
    RUSSELL, GJ
    FITZGERALD, JF
    CLARK, JH
    [J]. JOURNAL OF PEDIATRICS, 1987, 111 (03): : 313 - 319
  • [9] FULMINANT HEPATIC-FAILURE
    WENDON, JA
    WILLIAMS, R
    [J]. TRANSPLANTATION, 1994, 57 (01) : 165 - 166
  • [10] FULMINANT HEPATIC-FAILURE
    SHERLOCK, S
    [J]. ADVANCES IN INTERNAL MEDICINE, VOLUME 38, 1993, 38 : 245 - 267